INS and type 1 diabetes mellitus: Unfortunately, there is accumulating evidence of the limitations of exogenous insulin therapy of T1DM that result in bouts of dysglycemia, dyslipidemia, and insulin resistance, which contribute to the development of long-term diabetic complications, including cardiovascular disease, neuropathy, nephropathy, impaired protein synthesis, and loss of muscle tissue [4,5].